Scientia Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies.
Professor Dore has been President of the Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), a member of National Health and Medical Research Council (NHMRC) Council, and is a NHMRC Practitioner Fellow. He is a member of the Australian Academy of Health and Medical Sciences.
Professor Dore established the St Vincent’s Hospital viral hepatitis service in 1999, and has led its development into one of the leading national and international HCV treatment services, with a particular focus on marginalised populations including people who inject drugs and homeless persons. He has been involved in the Australian COVID-19 response largely through his work on the ADAPT post-COVID study at St Vincent's Hospital, and public health media work.